Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase I Study of an Oncofetal Antigen Multi-Peptide Immunotherapy in Subjects With Hematologic Cancer (BBMPI03)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02240537
Recruitment Status : Unknown
Verified April 2016 by Benovus Bio, Inc..
Recruitment status was:  Active, not recruiting
First Posted : September 15, 2014
Last Update Posted : April 19, 2016
Sponsor:
Information provided by (Responsible Party):
Benovus Bio, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : December 2016
Estimated Study Completion Date : June 2017